Why the study?
This article aims to address predicting and reducing perioperative major adverse cardiac events resulting from non-cardiac procedural complications.
Does severe pulmonary hypertension increase all-cause mortality at five years in patients undergoing TAVI?
Cohort (n=219)
No
Does severe pulmonary hypertension increase all-cause mortality at five years in patients undergoing TAVI?
Answers are grounded in this paper and cite their sources.
Severe pulmonary hypertension does not appear to significantly increase long-term (5-year) mortality after TAVI, though peripheral vascular disease and lower BMI are associated with reduced survival.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gary L. Murray (2020) conducted a cohort in Severe aortic stenosis (n=219). Severe pulmonary hypertension vs. Without severe pulmonary hypertension was evaluated on All-cause mortality at five years post-TAVI (adjusted HR 1.23, p=0.29).
Synapse has enriched 10 related papers. Consider them for comparative context: